ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2021

The Proportion Of IgG4-Related Aortitis In Patients Diagnosed As Chronic Inflammation Of Aorta In Pathology

Bon San Koo1, Bin Yoo1, Chang-Keun Lee1, You Jae Kim1, Seokchan Hong2, Yong-Gil Kim1, Wook Jang Seo3 and Kyung joo Ahn4, 1Division of Rheumatology, Department of Internal Medicine, University of Ulsan College of Medicine, Asan Medical Center, Seoul, South Korea, 2Department of rheumatology, Department of Internal Medicine, University of Ulsan College of Medicine, Asan Medical Center, Seoul, South Korea, 3Seoul Veterans Hospital, Seoul, South Korea, 4KEPCO medical center, Seoul, South Korea

Meeting: 2013 ACR/ARHP Annual Meeting

Keywords: IgG4 Related Disease and vasculitis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Miscellaneous Rheumatic and Inflammatory Diseases II: Miscellaneous Rheumatic Diseases

Session Type: Abstract Submissions (ACR)

Background/Purpose: The purpose of our study was to identify the proportion of IgG4-related aortitis in patients diagnosed with chronic inflammation of aorta in pathology and evaluate histological and clinical characteristics of IgG4-related aortitis.

Methods: We searched electronic medical records of pathologic reports including description of chronic inflammation in aorta specimen. Forty-seven patients had chronic inflammation of aorta and    immunostaining of IgG4 were performed on all biopsy specimen of aorta. If IgG4 positive plasma cell counts were more than 50 per high power field (HPF) and IgG4/IgG ratio were more than 40% with dense lymphoplasmacytic infiltration, fibrosis, or obliterative phlebitis, the patient classified as IgG4-related aortitis.

Results:

Total 47 patients who had chronic inflammation in pathologic specimen of aorta were identified which consisted of 29 idiopathic aortitis, 6 takayasu’s arteritis, 6 behcet’s disease, 3 infection, 3 graft failure patients. Among 29 idiopathic aortitis patients, three patients (10.3%) were classified as IgG4-related aortitis patients. The mean IgG4 positive plasma cell counts of IgG4-related aortitis and idiopathic aortitis were 120.0 ± 52.0 and 7.1 ± 11.7, respectively. One patients had thoracic aortic aneurysm and two patients had abdominal aortic aneurysm. The mean age of IgG4-related aortitis and idiopathic aortitis was 67.0 ± 2.0 and 54.7 ± 15.5 years, respectively (p=0.086). The sex ratio was all male (100%) in IgG4-related aortitis and 19 male in idiopathic aortitis (65%). In one IgG4-related aortitis patient, chronic pancreatitis with atrophy was observed. All IgG4-related aortitis patients underwent surgical treatement with no immunosuppressant. There was no recurrence of IgG4-related aortitis during follow-up period (45.3 ± 28.7 months).

Conclusion: The ratio of IgG4-related aortitis patients was 10% in patients which were diagnosed as idiopathic aortitis in the past. Although the small number of IgG4-related aortitis was found, the old and male patient who had chronic inflammation of aorta with no secondary cause might be related to IgG4-related disease.


Disclosure:

B. S. Koo,
None;

B. Yoo,
None;

C. K. Lee,
None;

Y. J. Kim,
None;

S. Hong,
None;

Y. G. Kim,
None;

W. J. Seo,
None;

K. J. Ahn,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2013 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/the-proportion-of-igg4-related-aortitis-in-patients-diagnosed-as-chronic-inflammation-of-aorta-in-pathology/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology